Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eugene Science is a South Korean biotechnology company that specialized in the development of functional food ingredients and nutraceuticals, primarily focusing on cardiovascular health. The company achieved significant recognition for its proprietary water-solubilization technology, which enabled the incorporation of hydrophobic plant sterols into various food and beverage formats. Its flagship product, Eu-cholesterol, was designed to lower LDL cholesterol levels and was commercialized through a major global licensing agreement with Archer Daniels Midland (ADM). Beyond its core cholesterol-lowering products, the company explored research into metabolic disorders and obesity. Although the company was previously listed on the KOSDAQ exchange, it has since undergone corporate restructuring and name changes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eugene Science.